Elisabet Cruces

Pharmaceutical Industry Analyst

Biopharma licensing activity in Q3 2019 51.8% higher than in Q3 2018

Total disclosed biopharma licensing exhibited strong growth in worldwide spend during the third quarter of 2019, driving a 51.8% increase to $37.2 billion from $24.5 billion in the same time period in 2018 (Figure 1). 1,377 new deals (excluding mergers & acquisitions and divestments) were registered in Q3 2019, an increase of 23.4% from 1,116 […]

Cortellis report: M&A value decreases by 7% to $105.3bn in Q2 2019

In early 2019, we released an in-depth analysis of 2018 deals activity. Here, we examine more recent activities and discuss mergers and acquisitions in the second quarter of 2019.   More deals, but lower total value Total disclosed biopharma mergers and acquisitions (M&A) value dropped slightly in the second quarter of 2019, down 7% from […]